Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Neuroprotection mediated through estrogen receptor-alpha in astrocytes.
Biogen Presents New Anti-LINGO-1 Phase 2 Acute Optic Neuritis Data Demonstrating Neurological Repair
Episode 38 with Dr. Joseph Berger on progressive multifocal leukoencephalopathy
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECTION): a multicentre, randomised, double-blind extension trial.
IL-17 and Th17 Cells.
Paternal therapy with disease modifying drugs in multiple sclerosis and pregnancy outcomes: a prospective observational multicentric study.
Long-Term Effects of Exposure to Disease-Modifying Drugs in the Offspring of Mothers with Multiple Sclerosis: A Retrospective Chart Review.
Gender and the hygiene hypothesis.
Heartbleed Bug
Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
Blood Brain Barrier Meeting
Nancy Davis Foundation Annual MS Expo and Health Forum
28th Congress of European Committee for Treatment and Research in Multiple Sclerosis Congress
Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Subjects With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex (SYNERGY)
Synthetic Biologics Reports UCLA Announcement of Preliminary Positive Topline Efficacy and Safety Results from Investigator-Led Phase II Study of Trimesta™ for RRMS
Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study.
Use of fumaric acid esters in psoriasis.
Episode 56 with Dr. Gavin Giovannoni, on early phase 3 results of ocrelizumab, the first experimental drug to show some benefit in a progressive form of multiple sclerosis in a major trial
FGF2 and FGFR1 signaling regulate functional recovery following cuprizone demyelination.
Webinar: Solutions for Genome Editing: TALEN, CRISPR, & Safe Harbor Integration
Setting a research agenda for progressive multiple sclerosis: The International Collaborative on Progressive MS.
IL-2Rβγ-signaling contributes to regulatory T cell maintenance and stability in daclizumab HYP-treated RRMS patients
The relevance of animal models in multiple sclerosis research.
Natalizumab strongly suppresses cortical pathology in relapsing-remitting multiple sclerosis.
Quantifying the early stages of remyelination following cuprizone-induced demyelination.

Pages